{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T04:43:58Z","timestamp":1789274638370,"version":"build-2803163510"},"reference-count":23,"publisher":"AACN Publishing","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,1]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Known as the \u201cgreat mimic,\u201d pheochromocytoma is rare and difficult to diagnose. When a pheochromocytoma begins to cause end-organ damage, it becomes pheochromocytoma multisystem crisis, an even more rare and deadly diagnosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical Findings<\/jats:title><jats:p>N.R., a 63-year old man, presented to the emergency department 1 day after receiving a cortisone injection for a nondisplaced wrist fracture. His chief concern was a \u201cracing heart and chest pressure.\u201d N.R. was admitted to the telemetry unit after routine electrocardiography showed atrial fibrillation and elevated blood pressure. Symptoms quickly progressed, and N.R. was transferred to the intensive care unit where he received noninvasive positive pressure ventilation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Diagnosis<\/jats:title><jats:p>A computed tomography scan revealed a 7-cm right intra-adrenal mass, and an echocardiogram showed a markedly reduced ejection fraction. N.R. received a preliminary diagnosis of pheochromocytoma multisystem crisis, although confirmatory laboratory test results were pending. N.R. became progressively more hemodynamically unstable and his respiratory status worsened, and by the end of hospital day 2 he had been intubated and was receiving multiple vasoactive medications intravenously. On hospital day 7, N.R. was transferred to a facility for definitive surgical intervention.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This case represents the importance of timely interventions by nursing staff, clear communication between staff on different shifts, and real-time education by physicians to nursing staff. This collaborative milieu empowered nurses to use their experience and critical thinking to make clinical decisions in providing care.<\/jats:p><\/jats:sec>","DOI":"10.4037\/ccn2021599","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T23:21:44Z","timestamp":1622589704000},"page":"25-32","source":"Crossref","is-referenced-by-count":2,"title":["Pheochromocytoma Multisystem Crisis: A Case Study"],"prefix":"10.4037","volume":"41","author":[{"given":"Barbara","family":"Endicott","sequence":"first","affiliation":[{"name":"Barbara Endicott is a bedside staff nurse, Asante Rogue Regional Medical Center, Medford, Oregon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb","family":"Wagoner","sequence":"additional","affiliation":[{"name":"Caleb Wagoner is a bedside nurse, Asante Rogue Regional Medical Center."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie","family":"Hibner","sequence":"additional","affiliation":[{"name":"Jessie Hibner is a family nurse practitioner, Asante Rogue Regional Medical Center."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Eckroth","sequence":"additional","affiliation":[{"name":"Josh Eckroth is a bedside and charge nurse in the mixed ICU, Asante Rogue Regional Medical Center."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2471","reference":[{"issue":"12","key":"2021060114501135700_b1-0410025","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1097\/01.hjh.0000251887.01885.54","article-title":"Pheochromocytoma: presentation, diagnosis and treatment","volume":"24","author":"Reisch","year":"2006","journal-title":"J Hypertens"},{"key":"2021060114501135700_b2-0410025","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5772\/intechopen.69338","article-title":"Pheochromocytoma crisis","volume-title":"Clinical Management of Adrenal Tumors","author":"Castelino","year":"2017"},{"issue":"1","key":"2021060114501135700_b3-0410025","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1210\/jc.2012-3020","article-title":"Pheochromocytoma crisis is not a surgical emergency","volume":"98","author":"Scholten","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2021060114501135700_b4-0410025","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jamcollsurg.2009.09.022","article-title":"Clinical spectrum of pheochromocytoma","volume":"209","author":"Guerrero","year":"2009","journal-title":"J Am Coll Surg"},{"issue":"6","key":"2021060114501135700_b5-0410025","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"51","author":"Calhoun","year":"2008","journal-title":"Hypertension"},{"key":"2021060114501135700_b6-0410025","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0002-9610(00)00296-8","article-title":"Adrenal pheochromocytoma remains a frequently overlooked diagnosis","volume":"179","author":"Lo","year":"2000","journal-title":"Am J Surg"},{"issue":"1","key":"2021060114501135700_b7-0410025","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1524-6175.2002.01452.x","article-title":"Pheochromocytoma","volume":"4","author":"Manger","year":"2007","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"2","key":"2021060114501135700_b8-0410025","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1530\/EJE-09-0384","article-title":"Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma","volume":"161","author":"Kopetschke","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2021060114501135700_b9-0410025","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1530\/EC-17-0321","article-title":"Initial clinical presentation and spectrum of pheochromocytoma: a study of 94 cases from a single center","volume":"7","author":"Falhammar","year":"2018","journal-title":"Endocr Connect"},{"issue":"1 pt 1","key":"2021060114501135700_b10-0410025","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/s0895-7061(99)00139-9","article-title":"Changes in clinical features and long-term prognosis in patients with pheochromocytoma","volume":"13","author":"Noshiro","year":"2000","journal-title":"Am J Hypertens"},{"issue":"6","key":"2021060114501135700_b11-0410025","first-page":"354","article-title":"Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series","volume":"56","author":"Sutton","year":"1981","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"2021060114501135700_b12-0410025","doi-asserted-by":"publisher","first-page":"M33","DOI":"10.1530\/EJE-15-0464","article-title":"Cushing\u2019s syndrome: update on signs, symptoms and biochemical screening","volume":"173","author":"Nieman","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2021060114501135700_b13-0410025","unstructured":"Oyasu\u2008R, Yang\u2008XJ, Yoshida\u2008O. What is the difference between pheochromocytoma and paraganglioma? What are the familial syndromes that have pheochromocytoma as a component? What are the pathologic features of pheochromocytoma indicating malignancy? In: Questions in Daily Urologic Practice: Updates for Urologists and Diagnostic Pathologists. Springer; 2008:280\u2013284. Accessed December 12, 2019. https:\/\/link.springer.com\/chapter\/10.1007\/978-4-431-72819-1_49"},{"issue":"2","key":"2021060114501135700_b14-0410025","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4149\/endo_2011_02_65","article-title":"Phaeochromocytoma: a catecholamine and oxidative stress disorder","volume":"45","author":"Pacak","year":"2011","journal-title":"Endocr Regul"},{"issue":"3","key":"2021060114501135700_b15-0410025","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/1097-0142(197203)29:3<744::AID-CNCR2820290331>3.0.CO;2-N","article-title":"Ultrastructural and biochemical correlates of adrenal and extra-adrenal pheochromocytoma","volume":"29","author":"Brown","year":"1972","journal-title":"Cancer"},{"issue":"6","key":"2021060114501135700_b16-0410025","first-page":"1154","article-title":"Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion","volume":"100","author":"Proye","year":"1986","journal-title":"Surgery"},{"issue":"2","key":"2021060114501135700_b17-0410025","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ecl.2011.02.002","article-title":"Hypertension in pheochromocytoma: characteristics and treatment","volume":"40","author":"Zuber","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"10","key":"2021060114501135700_b18-0410025","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/S0021-9258(18)96620-2","article-title":"Control of enzymatic synthesis of adrenaline in the adrenal medulla by adrenal cortical steroids","volume":"241","author":"Wurtman","year":"1966","journal-title":"J Biol Chem"},{"issue":"10","key":"2021060114501135700_b19-0410025","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.107.728840","article-title":"Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease","volume":"118","author":"Overgaard","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"2021060114501135700_b20-0410025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/0970-1591.194781","article-title":"Current perioperative management of pheochromocytomas","volume":"33","author":"Ramachandran","year":"2017","journal-title":"Indian J Urol"},{"key":"2021060114501135700_b21-0410025","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fneur.2014.00051","article-title":"\u03b21-Blockers lower norepinephrine release by inhibiting presynaptic, facilitating \u03b21-adrenoceptors in normotensive and hypertensive rats","volume":"5","author":"Berg","year":"2014","journal-title":"Front Neurol"},{"key":"2021060114501135700_b22-0410025","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/eje.1.01987","article-title":"Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2","volume":"153","author":"Huynh","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2021060114501135700_b23-0410025","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/jama.287.11.1427","article-title":"Biochemical diagnosis of pheochromocytoma: which test is best?","volume":"287","author":"Lenders","year":"2002","journal-title":"JAMA"}],"container-title":["Critical Care Nurse"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/aacnjournals.org\/ccnonline\/article-pdf\/41\/3\/25\/136253\/25.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/aacnjournals.org\/ccnonline\/article-pdf\/41\/3\/25\/136253\/25.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:24:15Z","timestamp":1725150255000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacnjournals.org\/ccnonline\/article\/41\/3\/25\/31464\/Pheochromocytoma-Multisystem-Crisis-A-Case-Study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6,1]]}},"URL":"https:\/\/doi.org\/10.4037\/ccn2021599","relation":{},"ISSN":["0279-5442","1940-8250"],"issn-type":[{"value":"0279-5442","type":"print"},{"value":"1940-8250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]}}}